Delivery Order SPE2DB22D1202-SPE2DB24FUPJ7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,639.74, is for the delivery of PREVNAR 13 syringes (0.5 mL) and has an ultimate completion date of October 2, 2023. This award is a standalone delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a significant...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,716.91, is for the delivery of PREVNAR 13 SYRINGE 0.5ML. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award with the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,675.12 delivery order is for the supply of PREVNAR 13 SYRINGE 0.5ML, a critical pharmaceutical product. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award, valued at $134,830.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of PREVNAR 13 SYRINGE 0.5ML, a critical medical commodity, for a period ending on March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This contract award is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,755.91 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the procurement of PREVNAR 13 SYRINGE 0.5ML medical supplies. The contract, valued at $7,639.03, is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 13 syringes. The $53,779.55 firm fixed-price contract has an ultimate completion date of August 26, 2022. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,162.14 firm fixed-price delivery order is for the procurement of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with an ultimate completion date of April 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $18,586.13 firm fixed-price delivery order is for the procurement of Prevnar 13 syringes. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $47,397.80 firm fixed price delivery order is for the supply of PREVNAR 13 syringes. The award is associated with a $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUPJ7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PREVNAR 13 syringes (0.5 mL). The delivery order, valued at $24,220.47, is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor on this order, with no major subcontractors identified. This award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 2/1/24 |